+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rheumatoid Arthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 91 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5730228
Description Jump to:
This report describes the global market size of Rheumatoid Arthritis Drugs from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Rheumatoid Arthritis Drugs as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment

  • sarilumab
  • tocilizumab
  • abatacept
  • tofacitinib
  • baricitinib
  • upadacitinib
  • filgotinib
  • Others

Companies Covered

  • Regeneron Pharmaceuticals/Sanofi
  • Genentech/Roche/Chugai Pharmaceutical
  • Bristol-Myers Squibb
  • Pfizer
  • Eli Lilly/Incyte
  • AbbVie
  • Gilead Sciences Inc./Galapagos NV
  • Amgen
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Rheumatoid Arthritis Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Rheumatoid Arthritis Drugs Market in North America (2019-2029)
8.1 Rheumatoid Arthritis Drugs Market Size
8.2 Rheumatoid Arthritis Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Rheumatoid Arthritis Drugs Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Rheumatoid Arthritis Drugs Market in South America (2019-2029)
9.1 Rheumatoid Arthritis Drugs Market Size
9.2 Rheumatoid Arthritis Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Rheumatoid Arthritis Drugs Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Rheumatoid Arthritis Drugs Market in Asia & Pacific (2019-2029)
10.1 Rheumatoid Arthritis Drugs Market Size
10.2 Rheumatoid Arthritis Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Rheumatoid Arthritis Drugs Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Rheumatoid Arthritis Drugs Market in Europe (2019-2029)
11.1 Rheumatoid Arthritis Drugs Market Size
11.2 Rheumatoid Arthritis Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Rheumatoid Arthritis Drugs Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Rheumatoid Arthritis Drugs Market in MEA (2019-2029)
12.1 Rheumatoid Arthritis Drugs Market Size
12.2 Rheumatoid Arthritis Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Rheumatoid Arthritis Drugs Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Rheumatoid Arthritis Drugs Market (2019-2024)
13.1 Rheumatoid Arthritis Drugs Market Size
13.2 Rheumatoid Arthritis Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Rheumatoid Arthritis Drugs Market Size by Type
Chapter 14 Global Rheumatoid Arthritis Drugs Market Forecast (2024-2029)
14.1 Rheumatoid Arthritis Drugs Market Size Forecast
14.2 Rheumatoid Arthritis Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Rheumatoid Arthritis Drugs Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Regeneron Pharmaceuticals/Sanofi
15.1.1 Company Profile
15.1.2 Main Business and Rheumatoid Arthritis Drugs Information
15.1.3 SWOT Analysis of Regeneron Pharmaceuticals/Sanofi
215.1.4 Regeneron Pharmaceuticals/Sanofi Rheumatoid Arthritis Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.2 Genentech/Roche/Chugai Pharmaceutical
15.2.1 Company Profile
15.2.2 Main Business and Rheumatoid Arthritis Drugs Information
15.2.3 SWOT Analysis of Genentech/Roche/Chugai Pharmaceutical
215.2.4 Genentech/Roche/Chugai Pharmaceutical Rheumatoid Arthritis Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.3 Bristol-Myers Squibb
15.3.1 Company Profile
15.3.2 Main Business and Rheumatoid Arthritis Drugs Information
15.3.3 SWOT Analysis of Bristol-Myers Squibb
215.3.4 Bristol-Myers Squibb Rheumatoid Arthritis Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.4 Pfizer
15.4.1 Company Profile
15.4.2 Main Business and Rheumatoid Arthritis Drugs Information
15.4.3 SWOT Analysis of Pfizer
215.4.4 Pfizer Rheumatoid Arthritis Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.5 Eli Lilly/Incyte
15.5.1 Company Profile
15.5.2 Main Business and Rheumatoid Arthritis Drugs Information
15.5.3 SWOT Analysis of Eli Lilly/Incyte
215.5.4 Eli Lilly/Incyte Rheumatoid Arthritis Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.6 AbbVie
15.6.1 Company Profile
15.6.2 Main Business and Rheumatoid Arthritis Drugs Information
15.6.3 SWOT Analysis of AbbVie
215.6.4 AbbVie Rheumatoid Arthritis Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.7 Gilead Sciences Inc./Galapagos NV
15.7.1 Company Profile
15.7.2 Main Business and Rheumatoid Arthritis Drugs Information
15.7.3 SWOT Analysis of Gilead Sciences Inc./Galapagos NV
215.7.4 Gilead Sciences Inc./Galapagos NV Rheumatoid Arthritis Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.8 Amgen
15.8.1 Company Profile
15.8.2 Main Business and Rheumatoid Arthritis Drugs Information
15.8.3 SWOT Analysis of Amgen
215.8.4 Amgen Rheumatoid Arthritis Drugs Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Rheumatoid Arthritis Drugs Report
Table Data Sources of Rheumatoid Arthritis Drugs Report
Table Major Assumptions of Rheumatoid Arthritis Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Rheumatoid Arthritis Drugs Picture
Table Rheumatoid Arthritis Drugs Classification
Table Rheumatoid Arthritis Drugs Applications
Table Drivers of Rheumatoid Arthritis Drugs Market
Table Restraints of Rheumatoid Arthritis Drugs Market
Table Opportunities of Rheumatoid Arthritis Drugs Market
Table Threats of Rheumatoid Arthritis Drugs Market
Table COVID-19 Impact For Rheumatoid Arthritis Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Rheumatoid Arthritis Drugs
Table Cost Structure Analysis of Rheumatoid Arthritis Drugs
Table Key End Users
Table Latest News of Rheumatoid Arthritis Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Rheumatoid Arthritis Drugs Market
Table Policy of Rheumatoid Arthritis Drugs Market
Table 2019-2029 North America Rheumatoid Arthritis Drugs Market Size
Figure 2019-2029 North America Rheumatoid Arthritis Drugs Market Size and CAGR
Table 2019-2029 North America Rheumatoid Arthritis Drugs Market Size by Application
Table 2019-2024 North America Rheumatoid Arthritis Drugs Key Players Revenue
Table 2019-2024 North America Rheumatoid Arthritis Drugs Key Players Market Share
Table 2019-2029 North America Rheumatoid Arthritis Drugs Market Size by Type
Table 2019-2029 United States Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Canada Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Mexico Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 South America Rheumatoid Arthritis Drugs Market Size
Figure 2019-2029 South America Rheumatoid Arthritis Drugs Market Size and CAGR
Table 2019-2029 South America Rheumatoid Arthritis Drugs Market Size by Application
Table 2019-2024 South America Rheumatoid Arthritis Drugs Key Players Revenue
Table 2019-2024 South America Rheumatoid Arthritis Drugs Key Players Market Share
Table 2019-2029 South America Rheumatoid Arthritis Drugs Market Size by Type
Table 2019-2029 Brazil Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Argentina Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Chile Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Peru Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Asia & Pacific Rheumatoid Arthritis Drugs Market Size
Figure 2019-2029 Asia & Pacific Rheumatoid Arthritis Drugs Market Size and CAGR
Table 2019-2029 Asia & Pacific Rheumatoid Arthritis Drugs Market Size by Application
Table 2019-2024 Asia & Pacific Rheumatoid Arthritis Drugs Key Players Revenue
Table 2019-2024 Asia & Pacific Rheumatoid Arthritis Drugs Key Players Market Share
Table 2019-2029 Asia & Pacific Rheumatoid Arthritis Drugs Market Size by Type
Table 2019-2029 China Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 India Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Japan Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 South Korea Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Southeast Asia Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Australia Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Europe Rheumatoid Arthritis Drugs Market Size
Figure 2019-2029 Europe Rheumatoid Arthritis Drugs Market Size and CAGR
Table 2019-2029 Europe Rheumatoid Arthritis Drugs Market Size by Application
Table 2019-2024 Europe Rheumatoid Arthritis Drugs Key Players Revenue
Table 2019-2024 Europe Rheumatoid Arthritis Drugs Key Players Market Share
Table 2019-2029 Europe Rheumatoid Arthritis Drugs Market Size by Type
Table 2019-2029 Germany Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 France Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 United Kingdom Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Italy Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Spain Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Belgium Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Netherlands Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Austria Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Poland Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Russia Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 MEA Rheumatoid Arthritis Drugs Market Size
Figure 2019-2029 MEA Rheumatoid Arthritis Drugs Market Size and CAGR
Table 2019-2029 MEA Rheumatoid Arthritis Drugs Market Size by Application
Table 2019-2024 MEA Rheumatoid Arthritis Drugs Key Players Revenue
Table 2019-2024 MEA Rheumatoid Arthritis Drugs Key Players Market Share
Table 2019-2029 MEA Rheumatoid Arthritis Drugs Market Size by Type
Table 2019-2029 Egypt Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Israel Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 South Africa Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Gulf Cooperation Council Countries Rheumatoid Arthritis Drugs Market Size
Table 2019-2029 Turkey Rheumatoid Arthritis Drugs Market Size
Table 2019-2024 Global Rheumatoid Arthritis Drugs Market Size by Region
Table 2019-2024 Global Rheumatoid Arthritis Drugs Market Size Share by Region
Table 2019-2024 Global Rheumatoid Arthritis Drugs Market Size by Application
Table 2019-2024 Global Rheumatoid Arthritis Drugs Market Share by Application
Table 2019-2024 Global Rheumatoid Arthritis Drugs Key Vendors Revenue
Figure 2019-2024 Global Rheumatoid Arthritis Drugs Market Size and Growth Rate
Table 2019-2024 Global Rheumatoid Arthritis Drugs Key Vendors Market Share
Table 2019-2024 Global Rheumatoid Arthritis Drugs Market Size by Type
Table 2019-2024 Global Rheumatoid Arthritis Drugs Market Share by Type
Table 2024-2029 Global Rheumatoid Arthritis Drugs Market Size by Region
Table 2024-2029 Global Rheumatoid Arthritis Drugs Market Size Share by Region
Table 2024-2029 Global Rheumatoid Arthritis Drugs Market Size by Application
Table 2024-2029 Global Rheumatoid Arthritis Drugs Market Share by Application
Table 2024-2029 Global Rheumatoid Arthritis Drugs Key Vendors Revenue
Figure 2024-2029 Global Rheumatoid Arthritis Drugs Market Size and Growth Rate
Table 2024-2029 Global Rheumatoid Arthritis Drugs Key Vendors Market Share
Table 2024-2029 Global Rheumatoid Arthritis Drugs Market Size by Type
Table 2024-2029 Rheumatoid Arthritis Drugs Global Market Share by Type

Companies Mentioned

  • Regeneron Pharmaceuticals/Sanofi
  • Genentech/Roche/Chugai Pharmaceutical
  • Bristol-Myers Squibb
  • Pfizer
  • Eli Lilly/Incyte
  • AbbVie
  • Gilead Sciences Inc./Galapagos NV
  • Amgen
  • Johnson & Johnson
  • UCB

Related Topics

Related Reports

Rheumatoid Arthritis Drugs Global Market Report 2024 - Product Image

Rheumatoid Arthritis Drugs Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Rheumatoid Arthritis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Rheumatoid Arthritis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 211 Pages
  • Global
From
Rheumatoid Arthritis Therapeutics - Global Strategic Business Report - Product Image

Rheumatoid Arthritis Therapeutics - Global Strategic Business Report

  • Report
  • 150 Pages
  • Global
From
Polyarticular Juvenile Idiopathic Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Polyarticular Juvenile Idiopathic Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 95 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.